retatrutide phase 2 results for weight loss: Study shows 30% body weight loss New Retatrutide Phase 3 Trial

Paired with configurable GLP-1 funding options, it creates smarter, future-ready employee wellness solutions with no unnecessary financial burden for employers

It's called retatrutide, and what makes retatrutide different is that it targets not just one or two, but three hormone receptors in the pancreas: GLP-1, GIP, and glucagon

10.1172/jci113539 338

What about the side effects

This may indicate that the effect of semaglutide on body weight reduction is relatively rapid-acting and dose-dependent, possibly resulting from the higher albumin affinity of semaglutide compared with liraglutide [18]

Explore our semaglutide weight-loss program